bioAffinity Technologies receives Canadian patent for lung cancer test

Go back to bioAffinity Technologies receives Canadian patent for lung cancer test
(NASDAQ: BIAF) Delayed: 0.84 --0 (-0%)
Previous Close $0.84    52 Week High
Open $0.84    52 Week Low
Day High $0.84    P/E N/A 
Day Low $0.84    EPS
Volume 7,473       

(NASDAQ: BIAFW) Delayed: 0.14 --0 (-0%)
Previous Close $0.14    52 Week High
Open $0.14    52 Week Low
Day High $0.14    P/E N/A 
Day Low $0.14    EPS
Volume 18,831